Skip to search formSkip to main contentSkip to account menu

HCV 796

Known as: HCV-796, HCV796 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

BenzofuransNesbuvirSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
125 DESPITE PERSISTENT HIGH PLASMA LEVELS PEGYLATED INTERFERON-ALPHA ONLY TRANSIENTLY INDUCES INTERFERON STIMULATED GENES IN THE LIVER OF PATIENTS WITH CHRONIC HEPATITIS C
2010
2010
Design and synthesis of HCV agents with sequential triple inhibitory potentials.
Review
2009
Review
2009
Approaches for the development of antiviral compounds: the case of hepatitis C virus.
Traditional methods for general drug discovery typically include evaluating random compound libraries for activity in relevant… 
2009
2009
Stomach: Quadruple therapy for Helicobacter pylori eradication
  • J. Gisbert
  • Nature Reviews Gastroenterology &Hepatology
  • 2009
  • Corpus ID: 26855630
The low success rates of standard triple-therapy regimens for eradication of Helicobacter pylori infection have led to… 
2009
2009
1 Slow-binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus
The binding affinity of four palm and thumb site representative non-nucleoside inhibitors (NNIs) of HCV polymerase NS5B to wild… 
2009
2009
959 SUBTYPE SPECIFIC RESISTANCE PROFILES AFTER SELECTION OF HCV GENOTYPE 1A OR GENOTYPE 1B REPLICONS WITH TELAPREVIR OR HCV-796
Highly Cited
2008
Highly Cited
2008
Selection and Characterization of Hepatitis C Virus Replicons Dually Resistant to the Polymerase and Protease Inhibitors HCV-796 and Boceprevir (SCH 503034)
ABSTRACT HCV-796 is a nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (NS5B) polymerase, and… 
Highly Cited
2007
Highly Cited
2007
[50] ANTIVIRAL ACTIVITY OF THE NON-NUCLEOSIDE POLYMERASE INHIBITOR, HCV-796, IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2b IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV
2007
2007
Dosing with HCV-796 in combination with peginterferon α-2b/ribavirin has been halted in its current phase II study
  • 2007
  • Corpus ID: 195171267
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)